Nat Prod Sci.  2018 Jun;24(2):88-92. 10.20307/nps.2018.24.2.88.

Garcinexanthone G, a Selective Butyrylcholinesterase Inhibitor from the Stem Bark of Garcinia atroviridis

Affiliations
  • 1Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.
  • 2School of Chemical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.
  • 3School of Distance Education, Universiti Sains Malaysia, 11800 Penang, Malaysia. tanwn@usm.my

Abstract

The present study was undertaken to investigate the isolated compounds from the stem bark of Garcinia atroviridis as potential cholinesterase inhibitors and the ligand-enzyme interactions of selected bioactive compounds in silico. The in vitro cholinesterase results showed that quercetin (3) was the most active AChE inhibitor (12.65 ± 1.57 µg/ml) while garcinexanthone G (6) was the most active BChE inhibitor (18.86 ± 2.41 µg/ml). It is noteworthy to note that compound 6 was a selective inhibitor with the selectivity index of 11.82. Molecular insight from docking interaction further substantiate that orientation of compound 6 in the catalytic site which enhanced its binding affinity as compared to other xanthones. The nature of protein-ligand interactions of compound 6 is mainly hydrogen bonding, and the hydroxyl group of compound 6 at C-10 is vital in BChE inhibition activity. Therefore, compound 6 is a notable lead for further drug design and development of BChE selective inhibitor.

Keyword

Garcinia atroviridis; Garcinexanthone G; Butyrylcholinesterase; Molecular docking

MeSH Terms

Butyrylcholinesterase*
Catalytic Domain
Cholinesterase Inhibitors
Cholinesterases
Computer Simulation
Drug Design
Garcinia*
Hydrogen Bonding
In Vitro Techniques
Quercetin
Xanthones
Butyrylcholinesterase
Cholinesterase Inhibitors
Cholinesterases
Quercetin
Xanthones
Full Text Links
  • NPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr